← Open Payments lookup

MORSAL MOHAMMADI: Open Payments

NPI 1407512205 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,281 in 55 payments from 34 companies in 2025. Trend: 2023 $733 · 2024 $1,297 · 2025 $1,281

Food & beverage: $1,113Education: $168
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$121
Aveo Pharmaceuticals, Inc.2$105
ABBVIE INC.6$100
SEAGEN INC.1$93
PFIZER INC.4$69
Novartis Pharmaceuticals Corporation3$66
Genentech USA, Inc.3$59
ADC THERAPEUTICS AMERICA, INC.3$59
Janssen Biotech, Inc.2$42
Genmab U.S., Inc.2$42

Products named: FOTIVDA, REBLOZYL, ZYNLONTA, PADCEV, Fabhalta, LYNPARZA, Tecentriq, EPKINLY.

Industry payments across NJ — which companies pay providers there.